Pregnancy outcomes in women with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 9, 2005, Pages 887-895

  Dumic, M ^a   Janjanin, N ^a   Ille, J ^a   Zunec R ^a   Spehar A ^a   Zlopasa, G ^a   Francetic, I ^a   New, Maria I ^b  

^a KBC Zagreb   (Croatia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

21 hydroxylase deficiency; Congenital adrenal hyperplasia; Fertility; Preconception counselling; Pregnancy

Indexed keywords

DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; PREDNISOLONE; STEROID 21 MONOOXYGENASE;

ADULT; ARTICLE; BIRTH RATE; CASE REPORT; CONGENITAL ADRENAL HYPERPLASIA; DISEASE CARRIER; DISEASE COURSE; DOSE RESPONSE; FAMILY HISTORY; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; OLIGURIA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL CARE; PRENATAL DIAGNOSIS; SALT LOSING NEPHRITIS;

EID: 27844447631     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.9.887     Document Type: Article

References (13)

1. Lo JC, Grumbach MM. Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 207-229.
2. Stikkelbroeck NMML, Hermus ARMM, Braat DDM, Otten BJ. Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Obstet Gynecol Surv 2003; 59: 275-284.
3. Lo JC, Schwitzgebel VM, Tyrrell JB, Fitzgerald PA, Kaplan SL, Conte FA, Grumbach MM. Normal female infants born of mothers with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 930-936.
4. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995; 80: 2322-2329.
5. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57: 320-326.
6. Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1995; 80: 2014-2020.
7. Jaaskelainen J, Hippeläinen M, Kiekara O, Voutilainen R. Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand 2000; 79: 687-692.
8. Krone N, Wachter I, Stefanidou M, Roscher AA, Schwartz HP. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 2001; 55: 523-529.
9. Zacharin M. Fertility and its complications in a patient with salt losing congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 1999; 12: 89-94.
10. Sachs BP, Kobelin C, Castro MA, Frigoletto F. The risk of lowering the Caesarian-delivery rate. N Engl J Med 1999; 340: 54-57.
11. Porter RJ, de Swiet M. Pregnancy in a patient with congenital adrenal hyperplasia. Pediatr Adolesc Gynecol 1983; 1: 39-45.
12. Yarnell RW, D'Alton ME, Steinbok VS. Pregnancy complicated by preeclampsia and adrenal insufficiency. Anesth Analg 1994; 78: 176-178.
13. Kai H, Nose O, Iida Y, Ono J, Harada T, Yabuuchi H. Female pseudohermaphroditism caused by maternal congenital adrenal hyperplasia. J Pediatr 1979; 95: 418-420.